section name header

Pronunciation ⬇

BILL-beh-ree

Classifications ⬆ ⬇

Therapeutic Classification: ocular agents, vascular agents

Indications ⬆ ⬇

Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.

REMS


Action ⬆ ⬇

  • Anthocyanidins in bilberry have a variety of effects including increased glycosaminoglycans synthesis, decreased vascular permeability, reduced membrane thickness, redistribution of microvascular blood flow, and formation of interstitial fluid.
Therapeutic effects:
  • Decreased inflammation.
  • Decreased edema.
  • Decreased blood glucose.
  • Improved circulation.

Pharmacokinetics ⬆ ⬇

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Eliminated by the kidneys.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
POunknownunknownunknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Endo: low blood sugar

GI: diarrhea, upset stomach

Hemat: bleeding, bruising

Interactions ⬆ ⬇

Natural-Drug Products:

Natural-Natural Products:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Vaccinium myrtillus, Tegens